SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

French Pharmaceutical Giant Partners with CureMatch

BIOTECH: Local Co. Gains Global Reach In Sales, MarketingCureMatch, a San Diego-based software startup that helps oncologists identify treatment options for patients, recently landed a big corporate partner.

Cullgen Raises $16M in Series A For Cancer Fighting Treatments

Cullgen, a San Diego-based biotechnology company, raised $16 million in a Series A funding round led by Sequoia Capital China and HighLight Capital.

• AirporTour, a San Diego-based company that is building interactive airport guides with audio tours. • Ciari Guitars Inc., a San Diego-based startup that makes foldable travel guitars. The company p

A division of Rady Children’s Hospital that deploys quick-turnaround genomic sequencing in puzzling cases has added six board members.

Tease photo

PhaseBio Drug Receives ‘Breakthrough’ Designation

PhaseBio’s drug that aims to stop bleeding events received a breakthrough drug designation from the U.S. Food and Drug Administration. That follows an initial public offering and promising test results.

Tease photo

Funding Puts EvoFem in Position for Product Launch

Through a private stock placement Evofem Biosciences raised $30 million and said a second tranche is expected to provide up to $50 million more as the company gets closer to asking for regulatory approval of its birth control gel.

Ad Astra Ventures Launches Third Cohort with Three San Diego Founders

San Diego accelerator program Ad Astra Ventures welcomed three female-led startups into its third cohort this summer.

Tease photo

Salk Institute Receives $35M for Plant Initiative Fighting Climate Change

The Salk Institute for Biological Studies is set to receive $35 million to develop plants that suck up large amounts of carbon from the atmosphere to fight climate change.

Turning Point Therapeutics Raises $166.5M in Public Debut

Cancer drug developer Turning Point Therapeutics raised $166.5 million in its public market debut, an amount that surpassed original company expectation.

Viracta Therapeutics Receives Orphan Drug Designation

Viracta Therapeutics will receive tax credits and other benefits under a recent orphan drug designation, the latest from a company that’s been in the news lately.

SDBJ Insider: Jacobs School Continues to Rise in Rankings

U.S. News and World Report has ranked UC San Diego’s Jacobs School of Engineering at No. 11 among the nation’s graduate engineering schools.

SD 500: Lada Rasochova

SDBJ 500 recap:Lada Rasochova has been involved with the commercialization of pharmaceutical and biotechnology products for the past 20 years.

Tease photo

PhaseBio Drug Garners Breakthrough Designation

PhaseBio’s drug that aims to stop bleeding events received a breakthrough drug designation from the U.S. Food and Drug Administration.

SD 500: Kara Bortone

SDBJ 500 recap: As head of JLabs San Diego, Kara Bortone helps translate science and technology findings into marketable consumer goods, from pharmaceuticals to medical devices.

Tease photo

Biotech Startup Cullgen Raises $16M Series A

San Diego biotech startup Cullgen raised $16 million from Sequoia Capital China and Highlight Capital.

Rady Children’s Institute for Genomic Medicine Adds 6 Board Members

A division of Rady Children’s Hospital that deploys quick-turnaround genomic sequencing in puzzling cases has added six board members.

MedImpact Announces Layoffs

San Diego-based MedImpact Healthcare Systems will lay off up to 64 employees, citing business consolidation.

Tease photo

Prev